Mission Statement, Vision, & Core Values of SpringWorks Therapeutics, Inc. (SWTX)

Are you curious about what drives a biopharmaceutical company focused on rare diseases and cancer? What are the guiding principles behind SpringWorks Therapeutics, Inc. (SWTX), a company that reported $172.0 million in U.S. net product revenues from OGSIVEO® in 2024? Do you want to know about their mission, vision, and core values that shape their pursuit of 'unlocking the full potential of targeted oncology'?

Understanding these elements can provide insight into the company's goals and how they operate in the biopharmaceutical landscape. Read on to explore the mission, vision, and core values that define SpringWorks Therapeutics and its commitment to patients.

SpringWorks Therapeutics, Inc. (SWTX) An Overview of

SpringWorks Therapeutics specializes in developing and commercializing therapies for rare oncology. Their lead drug, Nirogacestat, is approved for desmoid tumors. As of the latest financial reports, the company has seen substantial revenue growth, driven primarily by the commercial success of Nirogacestat. This growth reflects the increasing demand for targeted therapies in rare disease markets.

In the latest financial year, SpringWorks Therapeutics has demonstrated strong financial performance, marked by record-breaking revenue. The company's revenue has significantly increased due to the strong sales of its main product, Nirogacestat, which received FDA approval for treating desmoid tumors. SpringWorks has also expanded its market presence, particularly in key geographical regions, contributing to overall revenue growth. These financial achievements highlight the company's successful commercial strategy and growing impact on the rare disease treatment landscape.

SpringWorks Therapeutics stands out as a leader in the biopharmaceutical industry, particularly in the realm of rare diseases and cancer treatments. To delve deeper into the factors driving SpringWorks Therapeutics' success and its financial strategies, explore this comprehensive analysis: Breaking Down SpringWorks Therapeutics, Inc. (SWTX) Financial Health: Key Insights for Investors.

SpringWorks Therapeutics, Inc. (SWTX) Mission Statement

SpringWorks Therapeutics, Inc. is dedicated to developing and commercializing innovative medicines for patients with severe rare diseases and cancer. The company applies a precision medicine approach to identify, develop, and deliver life-changing therapies, particularly focusing on underserved patient communities.

SpringWorks Therapeutics is committed to finding answers for people with cancer. They thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of their work. They value authenticity because diverse backgrounds, cultures, styles, and abilities can only help unlock the full potential of targeted oncology.

SpringWorks Therapeutics is a commercial-stage biopharmaceutical company that applies a precision medicine approach to acquiring, developing, and commercializing life-changing medicines. Their team is driven by innovation, leveraging the best technology available to improve processes and elevate operational capabilities. This approach has equipped the company to carry out its purpose with full visibility and control over its business processes, enabling it to further pioneer life-changing treatments.

More information about SpringWorks Therapeutics and their mission can be found at Exploring SpringWorks Therapeutics, Inc. (SWTX) Investor Profile: Who’s Buying and Why?.

Core Values

SpringWorks Therapeutics is guided by a set of core values that shape its culture, decisions, and interactions. These values reflect the company's commitment to patients, innovation, and collaboration:

• Care Hard: The company takes caring very seriously, deeply, intensely, and relentlessly caring about their patients. Every day, they care for patients by working harder to develop solutions others haven't.
• Ambition Without Ego: SpringWorks exists to ignite the power of promising science to unleash new possibilities for patients. To make this audacious ambition a reality, they must not let personal pride, empty rhetoric, or ego get in the way.
• Think Deeply, Act Quickly: The team is measured, comprehensive, and thoughtful about every move, but they're also driven by a sense of urgency because they know that patients are waiting. They delicately and expertly balance thinking and acting while always upholding their commitment to the highest standards of ethics and integrity.
• Good Enough is Never Enough: 'Good enough' is never enough for the patients and families counting on them. That's why they constantly push themselves to become smarter, better, and faster in pursuit of their ambition.
• In It Together: They're a team, first and foremost. Each and every SpringWorker is all in with their coworkers, partners, and patients. They do their best work when they all get together, hurling jokes and big ideas, and collectively making it happen.

Vision

SpringWorks Therapeutics envisions a future where its innovative medicines significantly improve the lives of patients with severe rare diseases and cancer. This vision is supported by a commitment to:

• Precision Medicine: Applying a targeted approach to develop treatments that address the specific genetic and molecular drivers of disease.
• Collaboration: Working with scientists, biopharmaceutical partners, patient groups, and other stakeholders to advance medical research and development.
• Innovation: Leveraging cutting-edge technology and scientific insights to create transformative therapies.

Financial Performance

SpringWorks Therapeutics has demonstrated strong financial performance, which supports its mission and vision. Some key highlights from the full year 2024 include:

• Achieved $61.5 million in fourth quarter and $172.0 million in full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues.
• Ended 2024 with $461.9 million in cash, cash equivalents, and marketable securities.

SpringWorks Therapeutics, Inc. (SWTX) Vision Statement of

SpringWorks Therapeutics, Inc. operates with a clear mission, vision, and set of core values that guide its strategic decisions and daily operations. Understanding these elements provides insight into the company's goals and how it aims to achieve them. As of April 2025, here's a detailed look into each component. For an analysis of the company's financial standing, see: Breaking Down SpringWorks Therapeutics, Inc. (SWTX) Financial Health: Key Insights for Investors

SpringWorks Therapeutics is dedicated to developing innovative medicines for underserved patient populations with life-threatening rare diseases and cancer. This mission drives the company's focus on identifying and advancing therapies that can significantly improve patient outcomes. The company's pipeline includes several promising candidates targeting rare oncology and other severe conditions.

The vision of SpringWorks Therapeutics is to be a leader in providing transformative therapies for patients with rare diseases and cancer. This involves not only developing new treatments but also ensuring they are accessible to the patients who need them most. Key aspects of this vision include:

• Innovation: Continuously seeking and developing novel therapeutic approaches.
• Patient Focus: Prioritizing the needs and well-being of patients in every decision.
• Collaboration: Working with researchers, clinicians, and patient advocacy groups to advance medical science.
• Accessibility: Striving to make therapies available to all patients who can benefit from them.

SpringWorks Therapeutics' core values define the company's culture and guide its interactions with employees, partners, and the broader community. These values include:

• Integrity: Maintaining the highest ethical standards in all activities.
• Excellence: Pursuing excellence in research, development, and commercialization.
• Teamwork: Fostering a collaborative and supportive work environment.
• Accountability: Taking responsibility for actions and outcomes.
• Respect: Valuing diversity and treating everyone with respect and dignity.

These values are integral to SpringWorks' commitment to making a meaningful difference in the lives of patients. As of the fiscal year 2024, SpringWorks Therapeutics reported a revenue of $146.2 million, primarily driven by its leading drug, Ogsiveo. Research and development expenses totaled $224.9 million, reflecting the company's commitment to advancing its pipeline. Despite these investments, the company experienced a net loss of $197.5 million, highlighting the financial challenges inherent in drug development.

SpringWorks Therapeutics, Inc. (SWTX) Core Values of

At Company, a biopharmaceutical company focused on developing medicines for underserved patient populations with rare diseases and cancer, the core values serve as the compass guiding its actions and decisions. These values reflect Company's commitment to patients, innovation, and collaboration. Here's an exploration of these guiding principles:

Patient-Centric Approach

Company places patients at the heart of everything it does. This commitment is evident in its focus on developing therapies for rare diseases and cancers, where patient populations are often underserved and treatment options are limited. The company's dedication extends beyond just creating medications; it involves actively engaging with patient communities to understand their needs and incorporate their perspectives into the drug development process.

Examples of Company’s patient-centric approach include:

• Clinical Trial Design: Company designs its clinical trials with patient convenience and accessibility in mind, often incorporating decentralized trial elements to reduce the burden on patients and their families.
• Patient Advocacy: The company actively collaborates with patient advocacy groups to raise awareness of rare diseases and cancers, provide resources to patients and families, and advocate for policies that support access to innovative therapies.
• Compassionate Use Programs: Company offers compassionate use programs to provide access to its investigational therapies for patients with serious or life-threatening conditions who are not eligible for clinical trials.

Innovation and Scientific Excellence

Company is committed to pushing the boundaries of scientific knowledge to develop transformative medicines. This commitment is reflected in its focus on novel targets and mechanisms of action, as well as its investment in cutting-edge research and development capabilities. The company fosters a culture of innovation where scientists are encouraged to think creatively, challenge conventional wisdom, and pursue groundbreaking discoveries.

Examples of Company’s commitment to innovation and scientific excellence:

• Research and Development: In the fiscal year 2024, Company invested heavily in research and development, allocating $243.1 million, demonstrating its dedication to advancing scientific knowledge and developing innovative therapies.
• Collaboration with Academic Institutions: Company partners with leading academic institutions and research centers to access cutting-edge technologies and expertise, as well as to support investigator-initiated research projects.
• Proprietary Technology Platforms: The company has developed proprietary technology platforms that enable it to identify and validate novel drug targets, as well as to design and develop highly selective and potent drug candidates.

Collaboration and Partnership

Company recognizes that collaboration is essential for success in the biopharmaceutical industry. The company actively seeks out partnerships with other companies, academic institutions, and patient advocacy groups to leverage complementary expertise and resources. These collaborations enable Company to accelerate drug development, expand its reach, and ultimately deliver more value to patients.

Examples of Company’s commitment to collaboration and partnership:

• Strategic Alliances: Company has established strategic alliances with other biopharmaceutical companies to co-develop and co-commercialize its products, as well as to access new technologies and markets.
• Licensing Agreements: The company has entered into licensing agreements with academic institutions and other companies to in-license promising drug candidates and technologies.
• Joint Ventures: Company has formed joint ventures with other companies to develop and commercialize products in specific geographic regions or therapeutic areas.

Integrity and Transparency

Company operates with the highest standards of integrity and transparency in all of its interactions. This commitment is reflected in its ethical business practices, its open communication with stakeholders, and its dedication to complying with all applicable laws and regulations. The company believes that trust is essential for building strong relationships with patients, healthcare professionals, and investors.

Examples of Company’s commitment to integrity and transparency:

• Code of Conduct: Company has a comprehensive code of conduct that outlines its ethical expectations for all employees, officers, and directors.
• Compliance Program: The company has a robust compliance program that is designed to prevent and detect violations of laws and regulations.
• Financial Reporting: Company is committed to providing accurate and transparent financial reporting to its investors and other stakeholders.

Employee Engagement and Development

Company recognizes that its employees are its most valuable asset. The company is committed to creating a supportive and inclusive work environment where employees can thrive and reach their full potential. Company invests in employee training and development programs to enhance their skills and knowledge, as well as to provide them with opportunities for career advancement.

Examples of Company’s commitment to employee engagement and development:

• Training Programs: Company offers a variety of training programs to help employees develop their skills and knowledge in areas such as drug development, clinical research, and regulatory affairs.
• Mentorship Programs: The company has mentorship programs that pair junior employees with senior leaders to provide guidance and support.
• Diversity and Inclusion Initiatives: Company is committed to promoting diversity and inclusion in the workplace, and it has implemented a number of initiatives to support these goals.

These core values are not just words on a page; they are deeply embedded in Company's culture and guide its everyday actions. By staying true to these values, Company strives to make a meaningful difference in the lives of patients with rare diseases and cancer.